Randomized placebo controlled phase 1 study· 2013

A single ascending-dose study of muscle regulator ACE-031 in healthy volunteers

Attie KM, Borgstein NG, Yang Y, et al.

Muscle and Nerve

PubMed: 23169607
Evidence level: moderate
Verification: verified

Summary

Double-blind placebo-controlled single ascending-dose study of ACE-031 in healthy postmenopausal women.

Limitations

Small early-phase study in healthy postmenopausal women, single-dose exposure and surrogate body-composition outcomes.

Linked peptides

ACE-031

Important PeptiBrief is an educational information platform. It does not diagnose, prescribe, sell peptides, recommend dosing, encourage self-experimentation or replace qualified medical care. Published scientific evidence is kept separate from community observations and uncertainty.